BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27174292)

  • 1. Targeting aphA : a new high-throughput screening assay identifies compounds that reduce prime virulence factors of Vibrio cholerae.
    Bolger G; Roy S; Zapol'skii VA; Kaufmann DE; Schnürch M; Mihovilovic MD; Nandy RK; Tegge W
    J Med Microbiol; 2016 Jul; 65(7):678-687. PubMed ID: 27174292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae.
    Rasmussen L; White EL; Pathak A; Ayala JC; Wang H; Wu JH; Benitez JA; Silva AJ
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4134-43. PubMed ID: 21709090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The virulence transcriptional activator AphA enhances biofilm formation by Vibrio cholerae by activating expression of the biofilm regulator VpsT.
    Yang M; Frey EM; Liu Z; Bishar R; Zhu J
    Infect Immun; 2010 Feb; 78(2):697-703. PubMed ID: 19933826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
    Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
    Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
    Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
    PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MetR-regulated Vibrio cholerae metabolism is required for virulence.
    Bogard RW; Davies BW; Mekalanos JJ
    mBio; 2012; 3(5):. PubMed ID: 23015737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule inhibitors of toxT expression in Vibrio cholerae.
    Anthouard R; DiRita VJ
    mBio; 2013 Aug; 4(4):. PubMed ID: 23919997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.
    Shakhnovich EA; Sturtevant D; Mekalanos JJ
    Mol Microbiol; 2007 Dec; 66(6):1331-41. PubMed ID: 17986190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping binding sites for the virulence gene regulators AphA, AphB and cAMP-CRP at the Vibrio cholerae tcpPH promoter.
    Kovacikova G; Skorupski K
    Mol Microbiol; 2001 Jul; 41(2):393-407. PubMed ID: 11489126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Effects of CsrA in Vibrio cholerae.
    Butz HA; Mey AR; Ciosek AL; Crofts AA; Davies BW; Payne SM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana.
    Abana D; Gyamfi E; Dogbe M; Opoku G; Opare D; Boateng G; Mosi L
    BMC Infect Dis; 2019 Jan; 19(1):76. PubMed ID: 30665342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TcpA pilin sequences and colonization requirements for O1 and O139 vibrio cholerae.
    Rhine JA; Taylor RK
    Mol Microbiol; 1994 Sep; 13(6):1013-20. PubMed ID: 7854116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and Efficient Elimination of
    Oh YT; Kim HY; Kim EJ; Go J; Hwang W; Kim HR; Kim DW; Yoon SS
    Front Cell Infect Microbiol; 2016; 6():156. PubMed ID: 27900286
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of virulence gene expression in Vibrio cholerae by quorum sensing: HapR functions at the aphA promoter.
    Kovacikova G; Skorupski K
    Mol Microbiol; 2002 Nov; 46(4):1135-47. PubMed ID: 12421317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.
    Waldor MK; Mekalanos JJ
    J Infect Dis; 1994 Aug; 170(2):278-83. PubMed ID: 8035010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
    Waldor MK; Tschäpe H; Mekalanos JJ
    J Bacteriol; 1996 Jul; 178(14):4157-65. PubMed ID: 8763944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of histopathological features of Vibrio cholerae O1 El Tor and O139 Bengal infections in rabbit intestinal mucosa.
    Amin A; Ali A; Kurunathan S; Cheong TG; Al-Jashamy KA; Jaafar H; Zainuddin ZF; Ravichandran M; Lalitha P
    Histol Histopathol; 2009 May; 24(5):559-65. PubMed ID: 19283664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new level in the Vibrio cholerae ToxR virulence cascade: AphA is required for transcriptional activation of the tcpPH operon.
    Skorupski K; Taylor RK
    Mol Microbiol; 1999 Feb; 31(3):763-71. PubMed ID: 10048021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae.
    Sergeev G; Roy S; Jarek M; Zapolskii V; Kaufmann DE; Nandy RK; Tegge W
    BMC Microbiol; 2014 Feb; 14():49. PubMed ID: 24568688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.